Phoenix Holdings Ltd. Kamada LTD Call Options Transaction History
Phoenix Holdings Ltd.
- $7.93 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KMDA
# of Institutions
47Shares Held
5.91MCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny872KShares$6.13 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA606KShares$4.26 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA396KShares$2.79 Million0.48% of portfolio
-
Acadian Asset Management LLC Boston, MA274KShares$1.93 Million0.0% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3270KShares$1.9 Million0.11% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $315M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...